$0.370
-0.0286 (-7.18%)
At Close: Jun 03, 2026
Why Is Accuray (ARAY) Up 2.6% Since Last Earnings Report?
04:31pm, Friday, 25'th Feb 2022 Zacks Investment Research
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Accuray to Participate in the Cowen 42nd Annual Health Care Conference
01:00am, Friday, 25'th Feb 2022 Investors Accuray
Company to Take Part in Fireside Chat Monday, March 7, 2022 at 9:50am PST / 12:50pm EST SUNNYVALE, Calif. , Feb. 24, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Cowen 42nd Annual Health Care Conference taking place March 7-9, 2022 .
Global Surgical Robots Market (2022 to 2026) - Analysis By Component, Surgical Specialty and Region - ResearchAndMarkets.com
06:31pm, Monday, 21'st Feb 2022 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Surgical Robots Market" report has been added to ResearchAndMarkets.com''s offering. The global surgical robots market was valued at $8052.67 Million in the year 2020 with North America region leading the regional market share. Companies Mentioned Intuitive Surgical Stryker Corporation Medtronic Smith & Nephew Zimmer Biomet Accuray Incorporated Renishaw Asensus Surgical Medrobotics Corporation Think Surgical The market is projected to display momentous gr
3 Penny Stocks To Buy Now According To Reddit Traders
05:45pm, Friday, 11'th Feb 2022 PennyStocks
Reddit penny stocks for your February 2022 watch list.
The post 3 Penny Stocks To Buy Now According To Reddit Traders appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c
3 Penny Stocks To Buy Now According To Reddit Traders
12:45pm, Friday, 11'th Feb 2022
Reddit penny stocks for your February 2022 watch list. The post 3 Penny Stocks To Buy Now According To Reddit Traders appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c
Accuray''s TomoTherapy Superior To Conventional Radiotherapy In Preserving Heart, Lung Functioning
05:04pm, Thursday, 10'th Feb 2022 Benzinga
Accuray Incorporated (NASDAQ: ARAY ) announced data from a Phase 3 TomoBreast trial of TomoTherapy System (TT) versus conventional post-surgery radiotherapy (CR) for breast cancer designed to test the hypothesis that TT might reduce lung-heart toxicity. An analysis of patient-reported outcomes showed 10-year survival free of heart and Full story available on Benzinga.com
Accuray rises 10% as TomoTherapy preserves heart/lung function in breast cancer patients
01:14pm, Thursday, 10'th Feb 2022 Seeking Alpha
Accuray (ARAY) said data from a phase 3 trial, dubbed TomoBreast, suggested that post-surgery hypofractionated radiotherapy delivered with the TomoTherapy System is superior to…
Accuray (ARAY) Q2 Earnings Miss Estimates, Margins Down
03:25pm, Thursday, 27'th Jan 2022 Zacks Investment Research
Accuray (ARAY) registers growth in Products revenues during fiscal Q2, thereby partly driving its overall top line.
New Strong Sell Stocks for January 27th
01:15pm, Thursday, 27'th Jan 2022 Zacks Investment Research
ARAY, XAIR, and EMKR have been added to the Zacks Rank #5 (Strong Sell) List on January 27, 2022
New Strong Sell Stocks for January 27th
10:00am, Thursday, 27'th Jan 2022
ARAY, XAIR, and EMKR have been added to the Zacks Rank #5 (Strong Sell) List on January 27, 2022
Accuray (ARAY) Q2 2022 Earnings Call Transcript
03:30am, Thursday, 27'th Jan 2022 The Motley Fool
ARAY earnings call for the period ending December 31, 2021.
Accuray Incorporated (ARAY) CEO Joshua Levine on Q2 2022 Earnings Call Transcript
02:56am, Thursday, 27'th Jan 2022 Seeking AlphaAccuray (ARAY) Reports Break-Even Earnings for Q2
11:35pm, Wednesday, 26'th Jan 2022 Zacks Investment Research
Accuray (ARAY) delivered earnings and revenue surprises of -100% and 10.84%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Accuray Incorporated (ARAY) CEO Joshua Levine on Q2 2022 Earnings Call Transcript
09:56pm, Wednesday, 26'th Jan 2022
Accuray Incorporated (ARAY) CEO Joshua Levine on Q2 2022 Earnings Call Transcript
Accuray GAAP EPS of $0.00 in-line, revenue of $116.28M beats by $13.35M (NASDAQ:ARAY)
09:12pm, Wednesday, 26'th Jan 2022 Seeking Alpha
Accuray press release (ARAY): FQ2 GAAP EPS of $0.00 in-line.Revenue of $116.28M (+19.3% Y/Y) beats by $13.35M.Shares +10.57%.Gross orders of $85.4 million, an increase of 13…
Sign In
Buy ARAY